Comparison of two strategies for intensifying antihypertensive treatment: Low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalapril)

American Journal of Hypertension

Volumn 12, Issue 7, 1999, Pages 691-696

  Elliott, William J ^a   Montoro, Rafael ^a   Smith, David ^a   Leibowitz, Mark ^a   Hwang, Clara ^a   Gradman, Alan H ^a   Schleman, Margo ^a   Klibaner, Michael ^a  

^a NONE

Author keywords

Enalapril; Felodipine; Hypertension; Lexxel; Treatment

Indexed keywords

ENALAPRIL MALEATE; ENALAPRIL MALEATE PLUS FELODIPINE; FELODIPINE; UNCLASSIFIED DRUG;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; EDEMA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENALAPRIL; FELODIPINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0033002491     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00051-5     Document Type: Article

References (10)

1. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI): Arch Intern Med 1997;157:2413-2446.
2. Gueyffier F., Froment A., Gouton M. New meta-analysis of treatment trials of hypertension improving the estimate of therapeutic benefit . J Hum Hypertens. 10:1996;1-8.
3. Siegel D., Lopez J. Trends in antihypertensive drug use in the United States do the JNC V recommendations affect prescribing? JAMA. 278:1997;1745-1748.
4. Sica D.A. Fixed-dose combination antihypertensive drugs. Drugs. 48:1994;16-24.
5. Epstein M., Bakris G. Newer approaches to antihypertensive therapy use of fixed-dose combination therapy . Arch Intern Med. 156:1996;1969-1978.
6. Elliott W.J. The costs of treating hypertension. Epstein M. Calcium Antagonists in Clinical Medicine. Second Edition. 1998;513-526 Hanley & Belfus, Inc, Philadelphia.
7. Burris J., Weir M., Oparil S., et al. An assessment of diltiazem and hydrochlorothiazide in hypertension. JAMA. 263:1990;1507-1512.
8. Frishman W.H., Bryzinski B.S., Coulson L.R., et al. A multifactorial trial design to assess combination therapy in hypertension treatment with bisoprolol and hydrochlorothiazide . Arch Intern Med. 154:1994;1461-1468.
9. For the Enalapril-Felodipine ER Factorial Study Group Gradman AH, Cutler NR, Davis PJ, et al,: Combined enalapril and felodipine extended release (ER) for systemic hypertension. Am J Cardiol 1997;79:431-435.
10. Medispan Prescribing Pricing Guide. Medispan, Inc., Indianapolis, IN, June, 1998.